Medical marijuana is becoming one of the most popular alternative treatments for chronic The history of cannabis: Weed and pain control. Medicinal cannabis, or medicinal marijuana, is a therapy that has garnered much .. institutions control and dispense cannabis much like opioids for pain. As more patients turn to cannabis for pain relief, there is a need for additional It was not until the early 19th century that cannabis started to be.
and control cannabis: history The of Weed pain
Variability in medical marijuana laws in the United States. Market size and demand for marijuana in Colorado. The Marijuana Policy Group. Characteristics of adults seeking medical marijuana certification.
Public opinion and medical cannabis policies: National Academies of Sciences, Engineering, and Medicine. The health effects of cannabis and cannabinoids: The National Academies Press: The religious and medicinal uses of cannabis in China, India and Tibet. Li HL, Lin H. An archaeological and historical account of cannabis in China. History of therapeutic cannabis. Cannabis in medical practice. Jefferson, NC, , pp. History of cannabis in Western Medicine. Grotenhermen F, editor; , Russo E, editor.
The Haworth Integrative Healing Press: New York, , pp. Grinspoon L, Bakalar JB. New Haven, CT, Results from the national survey on drug use and health: Center for Behavioral Health Statistics and Quality: Mlezack R, Wall PD.
Relieving pain in america: Common chronic pain conditions in developed and developing countries: Towards a comprehensive assessment of chronic pain patients. Fibromyalgia and chronic pain syndromes: Kruger L, editor; , Light AR, editor.
Boca Raton, FL, Regulation of the NA v 1. Antidepressants and gabapentinoids in neuropathic pain: More educated emergency department patients are less likely to receive pain medication. Johnson B, Mosri D. Johnson B, Faraone SV. Outpatient detoxification completion and one month outcomes for opioid dependence: The comparative safety of analgesics in older adults with arthritis.
Interrelations between pain and alcohol: Persistent pain is associated with substance use after detoxification: Mental disorders among persons with chronic back or neck pain: US national prevalence and correlates of low back and neck pain among adults.
Chronic spinal pain and physical-mental comorbidity in the United States: National Institute on Alcohol Abuse and Alcoholism. Increased pain sensitivity in alcohol withdrawal syndrome. Pain, nicotine, and smoking: The role of anxiety and depression in bi-directional relations between pain and tobacco smoking. The effects of depression and smoking on pain severity and opioid use in patients with chronic pain.
Chronic musculoskeletal pain and cigarette smoking among a representative sample of Canadian adolescents and adults. Predicting aberrant drug behavior in patients treated for chronic pain: J Pain Symptom Manage. The relationship between cigarette smoking and chronic low back pain.
Acute analgesic effects of nicotine and tobacco in humans: The association between smoking and low back pain: Pain as a motivator of smoking: Smoking cigarettes as a coping strategy for chronic pain is associated with greater pain intensity and poorer pain-related function.
Tobacco smoking, nicotine dependence, and patterns of prescription opioid misuse: Prescription opioid abuse in chronic pain: Predicting opioid misuse by chronic pain patients: The role of opioids in pain management. National trends in pharmaceutical opioid related overdose deaths compared to other substance related overdose death: Freiden TR, Houry D. Reducing the risks of relief-the CDC opioid prescribing guideline. N Engl J Med. Drug addiction, dysregulation of reward and allostasis.
Alcohol dependence as a chronic pain disorder. Piomelli D, Sasso O. Peripheral gating of pain signals by endogenous lipid mediators. Cuurr Opin Investig Drugs. Endocannabinoid signaling and synaptic function.
The neuronal distribution of cannabinoid receptor type 1 in the trigeminal ganglion of the rat. Cannabinoid receptor 1 controls human mucosal-type mast cell degranulation and maturation in situ. J Allergy Clin Immunol. Distribution of cannabinoid receptor 1 CB1 and 2 CB2 on sensory nerve fibers and adnexal structures in human skin.
Guindon J, Hohmann AG. The endocannabinoid system and pain. A neuroscientist's guide to lipidomics. Transcriptome-based identification of new anti-anti-inflammatory and vasodilating properties of the n-3 fatty acid docosahexaenoic acid in vascular endothelial cell under proinflammatory conditions. An endocannabinoid mechanism for stress-induced analgesia. Medical marijuana for treatment of chronic pain and other medical and psychiatric problems, a clinical review.
Upregulation of spinal cannabinoidreceptors following nerve injury enhances the effect of WIN55, on neuropathic pain behaviour in rats. Cannabinoids attenuate capsaicin-evoked hyperalgesia through spinal and peripheral mechanisms. Dose-dependent effects of smoked cannabis on capsaicin-induced pain and hyperalgesia in healthy volunteers.
Lack of analgesia by oral standardized cannabis extract on acute inflammatory pain and hyperalgesia in volunteers. Cannabinoids for medical use: Efficacy of inhaled cannabis on painful diabetic neuropathy. A preliminary evaluation of the relationship of cannabinoid blood concentrations with the analgesic response to vaporized cannabis. The therapy cannot be prescribed, and states may require physicians authorizing patient use to be registered with local programs.
Despite the complexities in the logistics of continuing medicinal cannabis in the acute care setting, proponents of palliative care and continuity of care argue that prohibiting medicinal cannabis use disrupts treatment of chronic and debilitating medical conditions. Patients have been denied this therapy during acute care hospitalizations for reasons stated above. Legislation in Minnesota, as one example, has been amended to permit hospitals as facilities that can dispense and control cannabis use; similar legislative actions protecting nurses from criminal, civil, or disciplinary action when administering medical cannabis to qualified patients have been enacted in Connecticut and Maine.
Despite lingering controversy, use of botanical cannabis for medicinal purposes represents the revival of a plant with historical significance reemerging in present day health care. Legislation governing use of medicinal cannabis continues to evolve rapidly, necessitating that pharmacists and other clinicians keep abreast of new or changing state regulations and institutional implications.
Ultimately, as the medicinal cannabis landscape continues to evolve, hospitals, acute care facilities, clinics, hospices, and long-term care centers need to consider the implications, address logistical concerns, and explore the feasibility of permitting patient access to this treatment. Whether national policy—particularly with a new presidential administration—will offer some clarity or further complicate regulation of this treatment remains to be seen.
The authors report no commercial or financial interests in regard to this article. National Center for Biotechnology Information , U. Journal List P T v. Author information Copyright and License information Disclaimer. This article has been cited by other articles in PMC. Open in a separate window.
Access to marijuana through home cultivation, dispensaries, or some other system that is likely to be implemented;. Allows either smoking or vaporization of some kind of marijuana products, plant material, or extract. Schedules of controlled substances.
Department of Justice; Management of substance abuse: Behavioral health trends in the United States: Office of National Drug Control Policy. Answers to frequently asked questions about marijuana. Medicinal use of marijuana—polling results. N Engl J Med. Kondrad E, Reid A. J Am Board Fam Med. Moeller KE, Woods B.
Am J Pharm Educ. National Conference of State Legislatures. State medical marijuana laws. Food and Drug Administration.
FDA work on medical products containing marijuana. Food and Drug Administration; Mar, A Complete Guide to Cannabis. Park Street Press; Early medical use of cannabis. The Marihuana Tax Act of The advisability and feasibility of developing USP standards for medical cannabis. Pharmacopeial Convention; [Accessed August 5, ].
Encyclopedia of Drug Policy. State marijuana laws in map. Comparing cannabis with tobacco—again. National Institute on Drug Abuse. Should marijuana be a medical option? MacDonald K, Pappas K. A multi-facet therapeutic target. Care and feeding of the endocannabinoid system: International Union of Basic and Clinical Pharmacology.
Cannabinoid receptors and their ligands: Current status and prospects for cannabidiol preparations as new therapeutic agents. Zhornitsky S, Potvin S. Cannabidiol in humans—the quest for therapeutic targets. Pharmaceuticals Basel ; 5: Is legalization impacting the way people use cannabis? Int J Drug Policy. Pharmacokinetics and metabolism of the plant cannabinoids, delta9-tetrahydrocannabinol, cannabidiol, and cannabinol. Controlled cannabis vaporizer administration: Plasma delta-9 tetrahydrocannabinol concentrations and clinical effects after oral and intravenous administration and smoking.
Pharmacokinetics and pharmacodynamics of cannabinoids. Exogenous cannabinoids as substrates, inhibitors, and inducers of human drug metabolizing enzymes: Sativex oral mucosal spray. Marinol dronabinol capsules USP prescribing information. Adverse health effects of marijuana use. Association between cannabis and psychosis: Keep off the grass?
Cannabis, cognition, and addiction. Marijuana and lung diseases. Curr Opin Pulm Med. Cannabis use and risk of psychiatric disorders: Early cannabis use and estimated risk of later onset of depression spells: There are no federal laws legalizing the drug in either capacity, and there is no known lethal dose of cannabis, according to Dr. Wallace in reference to federal guidelines.
With regard to long-term safety and the use of medical cannabis to treat chronic pain, Dr. Wallace referenced a Canadian study by Ware et al published in the Journal of Pain in , which found no significant difference in risks between groups using controlled cannabis and not using it.
Wallace shared that his approach for treating patients with chronic pain who are currently using opioids has been to wean them off of opioids first, and then to introduce medical cannabis. His aim in moving to the medical cannabis is to continue to provide pain relief for the patient, but with fewer side effects and more functionality.
In some cases, he advises patients to begin cannabis as they wean off their opioid doses to help manage any withdrawal effects.
He noted a few important factors that influence how practitioners may determine dosing and delivery method, pointing out that more research is needed in both areas.
Because there is no current federal regulatory oversight on the production of medical marijuana, the final product is in the hands of the states, which vary in policies.
As a result, overall purity levels and contaminants of medical cannabis may be unknown. In terms of dosing, Dr. Wallace has found that habitual users report low-dose preference, which has been further documented in animal studies looking at conditioned placed preference versus aversion Braida D, Pozzi M, Cavallini R, Sala M, Neuroscienc e. There are also considerations to be made with regard to bi-phasic effects ie, low and high doses can have opposite effects depending on the user profile and the two compounds within cannabis.
THC users may experience a delayed euphoric effect, including pain relief and reduced inflammation, as they metabolize the compound. Cannabidiol CBD may provide distinct medicinal applications from THC, including antidepressant effects and reported minimal psychoactive effects. CBD has a very low affinity for the two receptors and should be used with caution when considering drug-to-drug interactions due to an effect on metabolism and blood levels.
Some seizure drugs, for example, might have a negative interaction with CBD, noted Dr. Overall tolerance to cannabis may be developed on the psychological side eg, increased heart rate, drop in blood pressure and the subjective side ie, a feeling of euphoria , but there has not been a demonstrated tolerance with analgesic effects, according to Dr.
Medicinal Cannabis: History, Pharmacology, And Implications for the Acute Care Setting
Pot. Weed. Dope, grass, reefer. Blunts, dabs and shatter. The list of names for the drug others are finding it brings them relief from chronic pain and other conditions. Cannabis has been around for millions of years, and historical writings. Historical & Regulatory Background. The use of medical marijuana dates back more than 5, years, specifically to relieve headache pain. Despite its. If you're considering trying medical cannabis for pain relief, here's how to speak with your doctor about getting a recommendation for the substance how to speak with your doctor about medical marijuana Getting Started.